Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Background A previous analysis in this trial showed that among patients with severe,
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …

Transcatheter aortic valve implantation (TAVI) has risen over the past 20 years as a safe and
effective alternative to surgical aortic valve replacement for treatment of severe aortic …

Background Self-expanding transcatheter heart valves (THVs) are associated with better
echocardiographic hemodynamic performance than balloon-expandable THVs and are …

Background Previous studies demonstrated transcatheter aortic valve replacement (TAVR)
with an earlier generation balloon-expandable valve to be noninferior to surgical aortic valve …

Aims Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is
associated with increased morbidity and mortality. The effect of transcatheter interventions to …

The impact of mild paravalvular regurgitation (PVR) after transcatheter aortic valve
implantation (TAVI) remains controversial. We evaluated the impact of mild PVR after TAVI …

Background Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic
valve (BAV) stenosis is technically challenging and is burdened by an increased risk of …

Mixed aortic valve disease (MAVD), defined by the concurrent presence of aortic stenosis
(AS) and insufficiency is frequently seen in patients who have undergone transcatheter …

Background Preprocedural computed tomography planning improves procedural safety and
efficacy of transcatheter aortic valve implantation (TAVI). However, contemporary imaging …